Medicines labeled for the same conditions

Alternatives to lapine t-lymphocyte immune globulin

7 other medicines are given the same way (intravenous) and in the same FDA class as lapine t-lymphocyte immune globulin or labeled mainly for the same use (organ transplant rejection); the others include 2 calcineurin inhibitor immunosuppressants, 1 antimetabolite immunosuppressant and 1 interleukin-2 receptor blocking antibody (FDA labels read October 8, 2026).

Which medicines are labeled for the same conditions as lapine t-lymphocyte immune globulin?

Organ transplant rejection lists all 13 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.

Medicine and FDA class	Shared indication	Generic labelers (intravenous)	Pharmacy cost	Boxed warning	Shortage
Lapine t-lymphocyte immune globulinimmunoglobulin g	this medicine	none listed	n/a	No	No current entry
Mycophenolate mofetilantimetabolite immunosuppressant	Organ transplant rejection	6 labelers	n/a	Yes	No current entry
Basiliximabinterleukin-2 receptor blocking antibody	Organ transplant rejection	none listed	n/a	Yes	No current entry
Tacrolimuscalcineurin inhibitor immunosuppressant	Organ transplant rejection	1 labeler	n/a	Yes	No current entry
Azathioprinepurine antimetabolite	Organ transplant rejection	1 labeler	n/a	Yes	No current entry
Belataceptselective t cell costimulation blocker	Organ transplant rejection	none listed	n/a	Yes	No current entry
Cyclosporinecalcineurin inhibitor immunosuppressant	Organ transplant rejection	none listed	n/a	Yes	No current entry
Sirolimusmtor inhibitor immunosuppressant	Organ transplant rejection	none listed	n/a	Yes	No current entry

Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)

What next?

Lapine t-lymphocyte immune globulin: the full record: label, generics, price, shortages, recalls